Report of three case studies with olanzapine for chronic pain
Olanzapine, an atypical antipsychotic, has broad spectrum psychotropic effects, affecting dopamine receptors 1, 2, and 3, 5-hydroxytryptamine 2A, 5-hydroxytryptamine 2C, muscarinic, alpha-adrenergic, alpha-adrenergic, and histamine H-sites. This unique pharmacologic property allows clinicians to use...
Gespeichert in:
| Veröffentlicht in: | The journal of pain 2003-04, Vol.4 (3), p.166-168 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 168 |
|---|---|
| container_issue | 3 |
| container_start_page | 166 |
| container_title | The journal of pain |
| container_volume | 4 |
| creator | Gorski, Eugene D. Willis, Kerry C. |
| description | Olanzapine, an atypical antipsychotic, has broad spectrum psychotropic effects, affecting dopamine receptors 1, 2, and 3, 5-hydroxytryptamine 2A, 5-hydroxytryptamine 2C, muscarinic, alpha-adrenergic, alpha-adrenergic, and histamine H-sites. This unique pharmacologic property allows clinicians to use the agent as an adjunct for pain control, particularly when the intensity of the pain is exacerbated by dysregulation of neurotransmitters. Three case studies are presented from a suburban family practice setting in which olanzapine has been successfully used to regulate pain perception in adults with chronic pain. [copy ] 2003 by the American Pain Society |
| doi_str_mv | 10.1054/jpai.2003.438 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71367740</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1526590003004899</els_id><sourcerecordid>71367740</sourcerecordid><originalsourceid>FETCH-LOGICAL-c337t-c43c0ea3905209a04b9ee91cf5372730c3d5722aaa6a14eb1657196bb1ec3e433</originalsourceid><addsrcrecordid>eNp1kD1PwzAQhi0EoqUwsiJPbCnnr7gZGFBVPqRKSAhmy3Euqqs2DnYCgl9PSisxMd0Nj9737iHkksGUgZI369b6KQcQUylmR2TMFJ9lMyn18e-eZ6oAGJGzlNYAjCmtT8mIyZxzzeSY3L5gG2JHQ027VUSkziakqesrj4l--m5Fw8Y237b1DdI6ROpWMTTe0aG3OScntd0kvDjMCXm7X7zOH7Pl88PT_G6ZOSF0lzkpHKAVBSgOhQVZFogFc7USmmsBTlRKc26tzS2TWLJcaVbkZcnQCZRCTMj1PreN4b3H1JmtTw43w2UY-mQ0E7nWEgYw24MuhpQi1qaNfmvjl2Fgdr7MzpfZ-TKDr4G_OgT35RarP_ogaAD0HsDhvQ-P0STnsXFY-YiuM1Xw_0T_ADo6eHo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71367740</pqid></control><display><type>article</type><title>Report of three case studies with olanzapine for chronic pain</title><source>Elsevier ScienceDirect Journals Complete - AutoHoldings</source><source>MEDLINE</source><creator>Gorski, Eugene D. ; Willis, Kerry C.</creator><creatorcontrib>Gorski, Eugene D. ; Willis, Kerry C.</creatorcontrib><description>Olanzapine, an atypical antipsychotic, has broad spectrum psychotropic effects, affecting dopamine receptors 1, 2, and 3, 5-hydroxytryptamine 2A, 5-hydroxytryptamine 2C, muscarinic, alpha-adrenergic, alpha-adrenergic, and histamine H-sites. This unique pharmacologic property allows clinicians to use the agent as an adjunct for pain control, particularly when the intensity of the pain is exacerbated by dysregulation of neurotransmitters. Three case studies are presented from a suburban family practice setting in which olanzapine has been successfully used to regulate pain perception in adults with chronic pain. [copy ] 2003 by the American Pain Society</description><identifier>ISSN: 1526-5900</identifier><identifier>EISSN: 1528-8447</identifier><identifier>DOI: 10.1054/jpai.2003.438</identifier><identifier>PMID: 14622714</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Analgesics, Non-Narcotic - therapeutic use ; Benzodiazepines ; Chronic Disease ; Female ; Humans ; Middle Aged ; Pain - drug therapy ; Pirenzepine - analogs & derivatives ; Pirenzepine - therapeutic use</subject><ispartof>The journal of pain, 2003-04, Vol.4 (3), p.166-168</ispartof><rights>2003 The American Pain Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c337t-c43c0ea3905209a04b9ee91cf5372730c3d5722aaa6a14eb1657196bb1ec3e433</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1054/jpai.2003.438$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,778,782,3539,27907,27908,45978</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14622714$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gorski, Eugene D.</creatorcontrib><creatorcontrib>Willis, Kerry C.</creatorcontrib><title>Report of three case studies with olanzapine for chronic pain</title><title>The journal of pain</title><addtitle>J Pain</addtitle><description>Olanzapine, an atypical antipsychotic, has broad spectrum psychotropic effects, affecting dopamine receptors 1, 2, and 3, 5-hydroxytryptamine 2A, 5-hydroxytryptamine 2C, muscarinic, alpha-adrenergic, alpha-adrenergic, and histamine H-sites. This unique pharmacologic property allows clinicians to use the agent as an adjunct for pain control, particularly when the intensity of the pain is exacerbated by dysregulation of neurotransmitters. Three case studies are presented from a suburban family practice setting in which olanzapine has been successfully used to regulate pain perception in adults with chronic pain. [copy ] 2003 by the American Pain Society</description><subject>Analgesics, Non-Narcotic - therapeutic use</subject><subject>Benzodiazepines</subject><subject>Chronic Disease</subject><subject>Female</subject><subject>Humans</subject><subject>Middle Aged</subject><subject>Pain - drug therapy</subject><subject>Pirenzepine - analogs & derivatives</subject><subject>Pirenzepine - therapeutic use</subject><issn>1526-5900</issn><issn>1528-8447</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kD1PwzAQhi0EoqUwsiJPbCnnr7gZGFBVPqRKSAhmy3Euqqs2DnYCgl9PSisxMd0Nj9737iHkksGUgZI369b6KQcQUylmR2TMFJ9lMyn18e-eZ6oAGJGzlNYAjCmtT8mIyZxzzeSY3L5gG2JHQ027VUSkziakqesrj4l--m5Fw8Y237b1DdI6ROpWMTTe0aG3OScntd0kvDjMCXm7X7zOH7Pl88PT_G6ZOSF0lzkpHKAVBSgOhQVZFogFc7USmmsBTlRKc26tzS2TWLJcaVbkZcnQCZRCTMj1PreN4b3H1JmtTw43w2UY-mQ0E7nWEgYw24MuhpQi1qaNfmvjl2Fgdr7MzpfZ-TKDr4G_OgT35RarP_ogaAD0HsDhvQ-P0STnsXFY-YiuM1Xw_0T_ADo6eHo</recordid><startdate>20030401</startdate><enddate>20030401</enddate><creator>Gorski, Eugene D.</creator><creator>Willis, Kerry C.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20030401</creationdate><title>Report of three case studies with olanzapine for chronic pain</title><author>Gorski, Eugene D. ; Willis, Kerry C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c337t-c43c0ea3905209a04b9ee91cf5372730c3d5722aaa6a14eb1657196bb1ec3e433</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Analgesics, Non-Narcotic - therapeutic use</topic><topic>Benzodiazepines</topic><topic>Chronic Disease</topic><topic>Female</topic><topic>Humans</topic><topic>Middle Aged</topic><topic>Pain - drug therapy</topic><topic>Pirenzepine - analogs & derivatives</topic><topic>Pirenzepine - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gorski, Eugene D.</creatorcontrib><creatorcontrib>Willis, Kerry C.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The journal of pain</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gorski, Eugene D.</au><au>Willis, Kerry C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Report of three case studies with olanzapine for chronic pain</atitle><jtitle>The journal of pain</jtitle><addtitle>J Pain</addtitle><date>2003-04-01</date><risdate>2003</risdate><volume>4</volume><issue>3</issue><spage>166</spage><epage>168</epage><pages>166-168</pages><issn>1526-5900</issn><eissn>1528-8447</eissn><abstract>Olanzapine, an atypical antipsychotic, has broad spectrum psychotropic effects, affecting dopamine receptors 1, 2, and 3, 5-hydroxytryptamine 2A, 5-hydroxytryptamine 2C, muscarinic, alpha-adrenergic, alpha-adrenergic, and histamine H-sites. This unique pharmacologic property allows clinicians to use the agent as an adjunct for pain control, particularly when the intensity of the pain is exacerbated by dysregulation of neurotransmitters. Three case studies are presented from a suburban family practice setting in which olanzapine has been successfully used to regulate pain perception in adults with chronic pain. [copy ] 2003 by the American Pain Society</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>14622714</pmid><doi>10.1054/jpai.2003.438</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1526-5900 |
| ispartof | The journal of pain, 2003-04, Vol.4 (3), p.166-168 |
| issn | 1526-5900 1528-8447 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_71367740 |
| source | Elsevier ScienceDirect Journals Complete - AutoHoldings; MEDLINE |
| subjects | Analgesics, Non-Narcotic - therapeutic use Benzodiazepines Chronic Disease Female Humans Middle Aged Pain - drug therapy Pirenzepine - analogs & derivatives Pirenzepine - therapeutic use |
| title | Report of three case studies with olanzapine for chronic pain |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T13%3A42%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Report%20of%20three%20case%20studies%20with%20olanzapine%20for%20chronic%20pain&rft.jtitle=The%20journal%20of%20pain&rft.au=Gorski,%20Eugene%20D.&rft.date=2003-04-01&rft.volume=4&rft.issue=3&rft.spage=166&rft.epage=168&rft.pages=166-168&rft.issn=1526-5900&rft.eissn=1528-8447&rft_id=info:doi/10.1054/jpai.2003.438&rft_dat=%3Cproquest_cross%3E71367740%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71367740&rft_id=info:pmid/14622714&rft_els_id=S1526590003004899&rfr_iscdi=true |